Gotham Asset Management’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-33,285
Closed -$636K 1448
2024
Q2
$636K Sell
33,285
-18,738
-36% -$479K 0.01% 1019
2024
Q1
$1.71M Buy
+52,023
New +$1.66M 0.03% 696
2022
Q4
Sell
-24,538
Closed -$882K 1239
2022
Q3
$882K Buy
24,538
+7,790
+47% +$274K 0.03% 692
2022
Q2
$514K Buy
16,748
+9,657
+136% +$281K 0.02% 776
2022
Q1
$229K Buy
+7,091
New +$186K 0.01% 1034
2017
Q3
Sell
-13,472
Closed -$342K 947
2017
Q2
$342K Buy
+13,472
New +$324K ﹤0.01% 812

Other funds holding EVH

Gotham Asset Management's EVH Position: Q3 2024 in Review

Gotham Asset Management sold out of Evolent Health (EVH) in Q3 2024, closing a stake of 33,285 shares — an estimated $636K sold.

Gotham Asset Management first reported a position in EVH in Q2 2017 and held it in 6 quarters. The position peaked at $1.71M in Q1 2024. 262 funds tracked by Wall St. Rank hold EVH as of Q3 2024.

  • Gotham Asset Management reported no remaining Evolent Health position as of Q3 2024 after selling out during the quarter.
  • Gotham Asset Management sold 33,285 Evolent Health shares in Q3 2024, an estimated $636K.
  • Gotham Asset Management first reported a position in Evolent Health in Q2 2017 and held it in 6 quarters.
  • Gotham Asset Management's Evolent Health position peaked at $1.71M in Q1 2024.
  • 262 funds tracked by Wall St. Rank held Evolent Health as of Q3 2024.

Based on Gotham Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.